|
1
|
Meinsohn MC, Smith OE, Bertolin K and
Murphy BD: The orphan nuclear receptors steroidogenic factor-1 and
liver receptor homolog-1: Structure, regulation, and essential
roles in mammalian reproduction. Physiol Rev. 99:1249–1279. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
George A, Kaye S and Banerjee S:
Delivering widespread BRCA testing and PARP inhibition to patients
with ovarian cancer. Nat Rev Clin Oncol. 14:284–296. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tung N, Domchek SM, Stadler Z, Nathanson
KL, Couch F, Garber JE, Offit K and Robson ME: Counselling
framework for moderate-penetrance cancer-susceptibility mutations.
Nat Rev Clin Oncol. 13:581–588. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ren C, Li X, Wang T, Wang G, Zhao C, Liang
T, Zhu Y, Li M, Yang C, Zhao Y and Zhang GM: Functions and
mechanisms of long noncoding RNAs in ovarian cancer. Int J Gynecol
Cancer. 25:566–569. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang LQ, Yang SQ, Wang Y, Fang Q, Chen
XJ, Lu HS and Zhao LP: Long noncoding RNA MIR4697HG promotes cell
growth and metastasis in human ovarian cancer. Anal Cell Pathol
(Amst). 2017:82678632017.PubMed/NCBI
|
|
6
|
Esposito R, Bosch N, Lanzos A, Polidori T,
Pulido-Quetglas C and Johnson R: Hacking the cancer genome:
Profiling therapeutically actionable long non-coding RNAs using
CRISPR-Cas9 screening. Cancer Cell. 35:545–557. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Spizzo R, Almeida MI, Colombatti A and
Calin GA: Long non-coding RNAs and cancer: A new frontier of
translational research? Oncogene. 31:4577–4587. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chu C, Spitale RC and Chang HY:
Technologies to probe functions and mechanisms of long noncoding
RNAs. Nat Struct Mol Biol. 22:29–35. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao
SD, Zhang Y, Yang L, Shan W, He Q, et al: Comprehensive genomic
characterization of long non-coding RNAs across human cancers.
Cancer Cell. 28:529–540. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartonicek N, Maag JL and Dinger ME: Long
noncoding RNAs in cancer: Mechanisms of action and technological
advancements. Mol Cancer. 15:432016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li T, Yang XD, Ye CX, Shen ZL, Yang Y,
Wang B, Guo P, Gao ZD, Ye YJ, Jiang KW and Wang S: Long noncoding
RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and
tumor progression by upregulating the expression of high mobility
group AT-hook 2 (HMGA2) gene. Cell Cycle. 16:224–231. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Peng L, Yuan XQ, Liu ZY, Li WL, Zhang CY,
Zhang YQ, Pan X, Chen J, Li YH and Li GC: High lncRNA H19
expression as prognostic indicator: Data mining in female cancers
and polling analysis in non-female cancers. Oncotarget.
8:1655–1667. 2017.PubMed/NCBI
|
|
13
|
Jiang C, Li X, Zhao H and Liu H: Long
non-coding RNAs: Potential new biomarkers for predicting tumor
invasion and metastasis. Mol Cancer. 15:622016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Meryet-Figuière M, Lambert B, Gauduchon P,
Vigneron N, Brotin E, Poulain L and Denoyelle C: An overview of
long non-coding RNAs in ovarian cancers. Oncotarget. 7:44719–44734.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baumgart S, Hölters S, Ohlmann CH, Bohle
R, Stöckle M, Ostenfeld MS, Dyrskjøt L, Junker K and Heinzelmann J:
Exosomes of invasive urothelial carcinoma cells are characterized
by a specific miRNA expression signature. Oncotarget.
8:58278–58291. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lo CM, Iqbal U and Jack Li YC: Automatic
methods for managements of cancer, medicine, and behavior. Comput
Methods Programs Biomed. 146:A12017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mok SC, Bonome T, Vathipadiekal V, Bell A,
Johnson ME, Wong KK, Park DC, Hao K, Yip DK, Donninger H, et al: A
gene signature predictive for outcome in advanced ovarian cancer
identifies a survival factor: Microfibril-associated glycoprotein
2. Cancer Cell. 16:521–532. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Konstantinopoulos PA, Spentzos D, Karlan
BY, Taniguchi T, Fountzilas E, Francoeur N, Levine DA and Cannistra
SA: Gene expression profile of BRCAness that correlates with
responsiveness to chemotherapy and with outcome in patients with
epithelial ovarian cancer. J Clin Oncol. 28:3555–3561. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gentric G, Kieffer Y, Mieulet V, Goundiam
O, Bonneau C, Nemati F, Hurbain I, Raposo G, Popova T, Stern MH, et
al: PML-regulated mitochondrial metabolism enhances
chemosensitivity in human ovarian cancers. Cell Metab. 29:156–173
e10. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lisowska KM, Olbryt M, Dudaladava V,
Pamuła-Piłat J, Kujawa K, Grzybowska E, Jarząb M, Student S,
Rzepecka IK, Jarząb B and Kupryjańczyk J: Gene expression analysis
in ovarian cancer-faults and hints from DNA microarray study. Front
Oncol. 4:62014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tung CS, Mok SC, Tsang YT, Zu Z, Song H,
Liu J, Deavers MT, Malpica A, Wolf JK, Lu KH, et al: PAX2
expression in low malignant potential ovarian tumors and low-grade
ovarian serous carcinomas. Mod Pathol. 22:1243–1250. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lili LN, Matyunina LV, Walker LD, Benigno
BB and McDonald JF: Molecular profiling predicts the existence of
two functionally distinct classes of ovarian cancer stroma. Biomed
Res Int. 2013:8463872013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yeung TL, Leung CS, Wong KK, Samimi G,
Thompson MS, Liu J, Zaid TM, Ghosh S, Birrer MJ and Mok SC: TGF-β
modulates ovarian cancer invasion by upregulating CAF-derived
versican in the tumor microenvironment. Cancer Res. 73:5016–5028.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Erol A, Niemira M and Kretowski AJ: Novel
approaches in ovarian cancer research against heterogeneity, late
diagnosis, drug resistance, and transcoelomic metastases. Int J Mol
Sci. 20(pii): E26492019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Franier B and Thompson M: Early stage
detection and screening of ovarian cancer: A research opportunity
and significant challenge for biosensor technology. Biosens
Bioelectron. 135:71–81. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Oberaigner W, Minicozzi P, Bielska-Lasota
M, Allemani C, de Angelis R, Mangone L and Sant M; Eurocare Working
Group, : Survival for ovarian cancer in Europe: The across-country
variation did not shrink in the past decade. Acta Oncol.
51:441–453. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shapira I, Oswald M, Lovecchio J, Khalili
H, Menzin A, Whyte J, Dos Santos L, Liang S, Bhuiya T, Keogh M, et
al: Circulating biomarkers for detection of ovarian cancer and
predicting cancer outcomes. Br J Cancer. 110:976–983. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Dochez V, Caillon H, Vaucel E, Dimet J,
Winer N and Ducarme G: Biomarkers and algorithms for diagnosis of
ovarian cancer: CA125, HE4, RMI and ROMA, a review. J Ovarian Res.
12:282019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li K, Hüsing A, Fortner RT, Tjønneland A,
Hansen L, Dossus L, Chang-Claude J, Bergmann M, Steffen A, Bamia C,
et al: An epidemiologic risk prediction model for ovarian cancer in
Europe: The EPIC study. Br J Cancer. 112:1257–1265. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Qin Y, Liu X, Pan L, Zhou R and Zhang X:
Long noncoding RNA MIR155HG facilitates pancreatic cancer
progression through negative regulation of miR-802. J Cell Biochem.
Jun 3–2019.(Epub ahead of print). View Article : Google Scholar
|
|
32
|
Huang Z, Luo Q, Yao F, Qing C, Ye J, Deng
Y and Li J: Identification of differentially expressed long
non-coding RNAs in polarized macrophages. Sci Rep. 6:197052016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hu T and Lu YR: BCYRN1, a c-MYC-activated
long non-coding RNA, regulates cell metastasis of non-small-cell
lung cancer. Cancer Cell Int. 15:362015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Martínez-Fernández M, Feber A, Dueñas M,
Segovia C, Rubio C, Fernandez M, Villacampa F, Duarte J,
López-Calderón FF, Gómez-Rodriguez MJ, et al: Analysis of the
Polycomb-related lncRNAs HOTAIR and ANRIL in bladder cancer. Clin
Epigenetics. 7:1092015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang A, Zhao JC, Kim J, Fong KW, Yang YA,
Chakravarti D, Mo YY and Yu J: LncRNA hotair enhances the
androgen-receptor-mediated transcriptional program and drives
castration-resistant prostate cancer. Cell Rep. 13:209–221. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang XD, Xu HT, Xu XH, Ru G, Liu W, Zhu
JJ, Wu YY, Zhao K, Wu Y, Xing CG, et al: Knockdown of long
non-coding RNA HOTAIR inhibits proliferation and invasiveness and
improves radiosensitivity in colorectal cancer. Oncol Rep.
35:479–487. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bolha L, Ravnik-Glavač M and Glavač D:
Long noncoding RNAs as biomarkers in cancer. Dis Markers.
2017:72439682017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Luo J, Qu J, Wu DK, Lu ZL, Sun YS and Qu
Q: Long non-coding RNAs: A rising biotarget in colorectal cancer.
Oncotarget. 8:22187–22202. 2017.PubMed/NCBI
|
|
39
|
Fatima R, Akhade VS, Pal D and Rao SM:
Long noncoding RNAs in development and cancer: Potential biomarkers
and therapeutic targets. Mol Cell Ther. 3:52015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Huang S, Qing C, Huang Z and Zhu Y: The
long non-coding RNA CCAT2 is up-regulated in ovarian cancer and
associated with poor prognosis. Diagn Pathol. 11:492016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nikpayam E, Tasharrofi B, Sarrafzadeh S
and Ghafouri-Fard S: The role of long non-coding RNAs in ovarian
cancer. Iran Biomed J. 21:3–15. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Tang Q, Ni Z, Cheng Z, Xu J, Yu H and Yin
P: Three circulating long non-coding RNAs act as biomarkers for
predicting NSCLC. Cell Physiol Biochem. 37:1002–1009. 2015.
View Article : Google Scholar : PubMed/NCBI
|
